Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-30 Sale | 2023-09-01 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 8,100 | $32 | $259,200 | 99,149 (Direct) | View |
| 2023-08-25 Sale | 2023-08-29 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 5,135 | $31.59 | $162,215 | 85,249 (Direct) | View |
| 2023-03-14 Sale | 2023-03-16 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank Sr VP, Quality, GMP Oper. & IT | 4,780 | $35.99 | $172,023 | 4,737 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-07 Exercise | 2023-09-07 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 2,500 | $0 | 7,165 (Direct) | View |
| 2023-09-07 Tax Withholding | 2023-09-07 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,182 | $32.1 | 7,165 (Direct) | View |
| 2023-09-07 Exercise | 2023-09-07 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 35,000 | $0 | 1,906,413 (Direct) | View |
| 2023-09-07 Tax Withholding | 2023-09-07 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 16,804 | $32.1 | 1,906,413 (Direct) | View |
| 2023-08-30 Exercise | 2023-09-01 5:00 pm | N/A 2030-02-21 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 8,100 | $0 | 99,149 (Direct) | View |
| 2023-08-30 Exercise | 2023-09-01 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 8,100 | $23.99 | 99,149 (Direct) | View |
| 2023-08-23 Option Award | 2023-08-25 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 35,000 | $0 | 1,923,217 (Direct) | View |
| 2023-08-23 Option Award | 2023-08-25 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 2,500 | $0 | 8,347 (Direct) | View |
| 2023-08-17 Option Award | 2023-08-21 5:10 pm | N/A 2033-08-17 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Sensenig Bethany Director | 24,153 | $0 | 24,153 (Direct) | View |
| 2023-05-11 Tax Withholding | 2023-05-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 709 | $36.47 | 2,650 (Direct) | View |
| 2023-05-11 Exercise | 2023-05-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 1,500 | $0 | 2,650 (Direct) | View |
| 2023-05-11 Tax Withholding | 2023-05-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 15,005 | $36.47 | 1,888,217 (Direct) | View |
| 2023-05-11 Exercise | 2023-05-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 31,250 | $0 | 1,888,217 (Direct) | View |
| 2023-05-11 Exercise | 2023-05-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 750 | $0 | 5,497 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-08 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 31,250 | $0 | 1,903,222 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-08 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 1,500 | $0 | 3,359 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-08 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 750 | $0 | 5,497 (Direct) | View |
| 2023-02-22 Disposition(A) | 2023-04-12 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 500 | $0 | 2,648 (Direct) | View |
| 2023-02-22 Option Award(A) | 2023-04-12 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 500 | $0 | 2,648 (Direct) | View |
| 2023-02-22 Tax Withholding(A) | 2023-04-12 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 193 | $38.57 | 2,648 (Direct) | View |
| 2023-02-22 Disposition(A) | 2023-04-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank Sr VP, Quality, GMP Oper. & IT | 750 | $0 | 11,478 (Direct) | View |
| 2023-02-22 Option Award(A) | 2023-04-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank Sr VP, Quality, GMP Oper. & IT | 750 | $0 | 11,478 (Direct) | View |
| 2023-02-22 Tax Withholding(A) | 2023-04-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank Sr VP, Quality, GMP Oper. & IT | 289 | $38.57 | 11,478 (Direct) | View |
| 2023-02-22 Disposition(A) | 2023-04-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 750 | $0 | 92,284 (Direct) | View |
| 2023-02-22 Option Award(A) | 2023-04-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 750 | $0 | 92,284 (Direct) | View |
| 2023-02-22 Tax Withholding(A) | 2023-04-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 289 | $38.57 | 92,284 (Direct) | View |
| 2023-04-11 Option Award | 2023-04-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,500 | $0 | 4,747 (Direct) | View |
| 2023-03-14 Exercise | 2023-04-10 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 1,500 | $0 | 2,052 (Direct) | View |
| 2023-03-14 Tax Withholding | 2023-04-10 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 789 | $38.65 | 2,052 (Direct) | View |
| 2023-03-14 Exercise | 2023-04-10 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 20,000 | $0 | 1,871,972 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:04 pm | N/A 2033-02-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 25,000 | $0 | 28,247 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:03 pm | N/A 2033-02-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 25,000 | $0 | 27,497 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:03 pm | N/A 2033-02-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 50,000 | $0 | 51,341 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:03 pm | N/A 2033-02-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 25,000 | $0 | 115,323 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:02 pm | N/A 2033-02-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 280,000 | $0 | 2,131,972 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:02 pm | N/A 2033-02-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 10,179 | $0 | 45,046 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:02 pm | N/A 2033-02-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 10,179 | $0 | 122,311 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:01 pm | N/A 2033-02-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director | 10,179 | $0 | 23,494 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:01 pm | N/A 2033-02-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 10,179 | $0 | 23,494 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:01 pm | N/A 2033-02-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director | 10,179 | $0 | 94,236 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:00 pm | N/A 2033-02-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 37,500 | $0 | 47,017 (Direct) | View |
| 2023-02-22 Disposition | 2023-02-24 5:16 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director | 3,882 | $0 | 84,057 (Direct) | View |
| 2023-02-22 Option Award | 2023-02-24 5:16 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director | 3,882 | $0 | 84,057 (Direct) | View |
| 2023-02-22 Disposition | 2023-02-24 5:14 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 3,882 | $0 | 13,315 (Direct) | View |
| 2023-02-22 Option Award | 2023-02-24 5:14 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 3,882 | $0 | 13,315 (Direct) | View |
| 2023-02-22 Disposition | 2023-02-24 5:12 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director | 3,882 | $0 | 13,315 (Direct) | View |
| 2023-02-22 Option Award | 2023-02-24 5:12 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director | 3,882 | $0 | 13,315 (Direct) | View |
| 2023-02-22 Disposition | 2023-02-24 5:11 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 3,882 | $0 | 34,867 (Direct) | View |
| 2023-02-22 Option Award | 2023-02-24 5:11 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 3,882 | $0 | 34,867 (Direct) | View |
| 2023-02-22 Disposition | 2023-02-24 5:08 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 3,882 | $0 | 112,132 (Direct) | View |
| 2023-02-22 Option Award | 2023-02-24 5:08 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 3,882 | $0 | 112,132 (Direct) | View |
| 2023-02-22 Disposition | 2023-02-24 5:06 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 750 | $0 | 5,497 (Direct) | View |
| 2023-02-22 Option Award | 2023-02-24 5:06 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 750 | $0 | 5,497 (Direct) | View |
| 2023-02-22 Disposition | 2023-02-24 5:03 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 500 | $0 | 2,841 (Direct) | View |
| 2023-02-22 Option Award | 2023-02-24 5:03 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 500 | $0 | 2,841 (Direct) | View |
| 2023-02-22 Disposition | 2023-02-24 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 750 | $0 | 92,573 (Direct) | View |
| 2023-02-22 Option Award | 2023-02-24 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 750 | $0 | 92,573 (Direct) | View |